Lorentz Brinch
Position:
Phone:
Email:
 

Author network for Lorentz Brinch by COREMINE medical


Publications 2016

Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
Clin Microbiol Infect, 23 (3), 179-187
PubMed 27793737

Publications 2015

Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
Ther Drug Monit, 37 (4), 493-500
PubMed 25565670

Publications 2014

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
Tidsskr Nor Laegeforen, 134 (16), 1569-75
PubMed 25178233

Publications 2013

Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socié G, Tischer J, Oneto R, Passweg J, Marsh J (2013)
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
Haematologica, 98 (11), 1804-9
PubMed 23894010

Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2013)
Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions
Transplantation, 96 (4), e21-2
PubMed 23958883

Publications 2012

Akkök CA, Haugaa H, Galgerud A, Brinch L (2012)
Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
Transfus Apher Sci, 48 (1), 63-6
PubMed 22902604

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
PubMed 22522568

Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2012)
Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
Bone Marrow Transplant, 48 (5), 703-7
PubMed 23064037

Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V, Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) (2012)
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients
J Intern Med, 272 (5), 472-83
PubMed 22519980

Publications 2011

Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B, Nordic MPD Study Group (2011)
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
Bone Marrow Transplant, 47 (3), 380-6
PubMed 21552298

Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, Franklin IM, O'Riordan J, Rovira M, Shaw P, Einsele H, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (2011)
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
Bone Marrow Transplant, 47 (9), 1217-21
PubMed 22158388

Wang Y, Brinch L, Jebsen P, Tanbo T, Kirschner R (2011)
A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation
Biol Blood Marrow Transplant, 18 (5), 747-53
PubMed 21963879

Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P, EBMT Chronic Leukemia Working Party (2011)
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
Leukemia, 26 (5), 972-6
PubMed 22116553

Publications 2008

Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
[Allogeneic stem cell transplantation in acute myelogenous leukemia]
Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
PubMed 18704137

Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
[Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
Tidsskr Nor Laegeforen, 128 (22), 2563-6
PubMed 19023351

Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
J Am Coll Cardiol, 51 (6), 674-6
PubMed 18261689

Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
[High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
Tidsskr Nor Laegeforen, 128 (12), 1392-6
PubMed 18552900

Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T, complications subcommittee of the Chronic Leukemia Working Party (2008)
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
Bone Marrow Transplant, 42 (11), 739-42
PubMed 18724394

Publications 2007

Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J (2007)
Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
Vox Sang, 93 (1), 42-8
PubMed 17547564

Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L (2007)
[Non-myeloablative allogeneic stem cell transplantation]
Tidsskr Nor Laegeforen, 127 (6), 721-4
PubMed 17363982

Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
Leukemia, 21 (10), 2203-4
PubMed 17525727

Publications 2006

Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Nordic Myeloma Study Group (2006)
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
Haematologica, 91 (9), 1228-33
PubMed 16956822

Lenhoff S, Hjorth M, Westin J, Brinch L, Bäckström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I, Nordic Myeloma Study Group (2006)
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group
Br J Haematol, 133 (4), 389-96
PubMed 16643445

Publications 2005

Mishra V, Andresen S, Brinch L, Kvaløy S, Ernst P, Lønset MK, Tangen JM, Wikelund J, Flatum C, Baggerød E, Helle B, Vaaler S, Hagen TP (2005)
Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
Bone Marrow Transplant, 35 (12), 1149-53
PubMed 15880133

Publications 2004

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
[Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
Tidsskr Nor Laegeforen, 124 (6), 768-70
PubMed 15039804

Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
Bone Marrow Transplant, 34 (4), 345-50
PubMed 15170163

Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004)
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation
Bone Marrow Transplant, 34 (3), 257-66
PubMed 15170167

Lund MB, Brinch L, Kongerud J, Boe J (2004)
Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
Eur Respir J, 23 (6), 901-5
PubMed 15219005

Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
[Clinical use of haematopoietic stem cells from cord blood]
Tidsskr Nor Laegeforen, 124 (22), 2928-31
PubMed 15550970

Tiercy JM, Passweg J, van Biezen A, Zander A, Kröger N, Gratwohl A, Chapuis B, Helg C, Brinch L, Cornelissen J, Oudshoorn M, Ruutu T, Volin L, Niederwieser D, Roosnek E, Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT) (2004)
Isolated HLA-C mismatches in unrelated donor transplantation for CML
Bone Marrow Transplant, 34 (3), 249-55
PubMed 15195077

Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
Haemophilia, 10 (2), 174-8
PubMed 14962207

Publications 2003

Bergheim J, Ernst P, Brinch L, Gore DM, Chetty MC, Stewart GW (2003)
Allogeneic bone marrow transplantation for severe post-splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
Br J Haematol, 121 (1), 119-22
PubMed 12670341

Gruber A, Bjorkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Lofvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Uden AM, Paul C, Liliemark J (2003)
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
Leuk. Res., 27 (4), PII S0145-2126(02)00181-9-328

Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J (2003)
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
Leuk Res, 27 (4), 323-8
PubMed 12531223

Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
Bone Marrow Transplant, 32 (3), 257-64
PubMed 12858196

Mishra V, Vaaler S, Brinch L (2003)
Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
Clin Lab Haematol, 25 (3), 179-84
PubMed 12755795

Wisløff F, Brinch L, Hammerstrøm J (2003)
[National guidelines for treatment of chronic myelogenous leukemia]
Tidsskr Nor Laegeforen, 123 (2), 157-9
PubMed 12607495

Publications 2002

Dalgaard J, Brinch L, Tjønnfjord GE (2002)
[Paroxysmal nocturnal hemoglobinuria--a rare disease with many faces]
Tidsskr Nor Laegeforen, 122 (4), 374-8
PubMed 11915665

Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA (2002)
Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
Bone Marrow Transplant, 29 (6), 479-86
PubMed 11960266

Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, Bertz H, Ljungman P, Spence D, Verdonck LF, Prentice HG, Bosi A, Du Toit CE, Brinch L, Apperley JF, EBMT Chronic Leukaemia Working Party (2002)
Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
Br J Haematol, 118 (4), 1112-9
PubMed 12199793

Publications 2001

Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J, Nordic Myeloma Study Group (2001)
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
Med Oncol, 18 (1), 65-77
PubMed 11778972

Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, Brinch L, Brune M, De La Camara R, Dekker A, Pauksen K, Russell N, Schwarer AP, Cordonnier C (2001)
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Bone Marrow Transplant, 28 (5), 479-84
PubMed 11593321

Melsom T, Brinch L, Hessen JO, Schei MA, Kolstrup N, Jacobsen BK, Svanes C, Pandey MR (2001)
Asthma and indoor environment in Nepal
Thorax, 56 (6), 477-81
PubMed 11359965

Mishra V, Vaaler S, Brinch L (2001)
A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures
Bone Marrow Transplant, 28 (12), 1111-6
PubMed 11803351

Wisløff F, Tangen JM, Brinch L, Dahl IM, Gruber FX, Hammerstrøm J, Waage A, Nesthus I, Ernst P (2001)
[High dose therapy with autologous stem cell support--finally a progress in myelomatosis]
Tidsskr Nor Laegeforen, 121 (20), 2402-6
PubMed 11603051

Publications 2000

Dalgaard J, Ritland S, Brinch L, Ikonomou IM (2000)
[Mastocytosis--a review illustrated by two case reports]
Tidsskr Nor Laegeforen, 120 (11), 1312-5
PubMed 10868093

Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA (2000)
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
Bone Marrow Transplant, 25 (11), 1129-36
PubMed 10849524

Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen HE, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S (2000)
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group
Blood, 95 (1), 7-11
PubMed 10607678

Nordbø SA, Skaug K, Holter E, Waage A, Brinch L (2000)
Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation
Eur J Haematol, 65 (1), 86-7
PubMed 10914949

Publications 1999

Brinch L (1999)
[Transplantation with allogenic hematopoietic stem cells in adults]
Tidsskr Nor Laegeforen, 119 (27), 4045-9
PubMed 10613095

Kerty E, Vigander K, Flage T, Brinch L (1999)
Ocular findings in allogeneic stem cell transplantation without total body irradiation
Ophthalmology, 106 (7), 1334-8
PubMed 10406617

Lamvik J, Brinch L, Dahl IM, Sjo M, Nesthus I, Tangen JM, Berentsen S, Ly B, Shammas FV (1999)
[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96]
Tidsskr Nor Laegeforen, 119 (12), 1733-6
PubMed 10380587

Torfoss D, Aukrust P, Brinch L, Mathiesen O, Simonsen GS, Axelsen AK, Gaustad P (1999)
Carrier rate of resistant enterococci in a tertiary care hospital in Norway
APMIS, 107 (6), 545-9
PubMed 10379681

Publications 1998

Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, Stenstad T (1998)
Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
Scand J Rheumatol, 27 (4), 257-64
PubMed 9751465

Publications 1997

Ruutu T, Ljungman P, Brinch L, Lenhoff S, Lönnqvist B, Ringdén O, Ruutu P, Volin L, Albrechtsen D, Sallerfors B, Ebeling F, Myllylä G (1997)
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group
Bone Marrow Transplant, 19 (3), 233-6
PubMed 9028551

Tangen JM, Abdelnoor M, Brinch L, Dahl IM, Lamvik J, Ly B, Nesthus I, Wisløff F (1997)
Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995
Eur J Haematol, 59 (2), 110-4
PubMed 9293859

Wahlin A, Brinch L, Hörnsten P, Evensen SA, Oberg G, Simonsson B, Hedenus M (1997)
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia
Eur J Haematol, 58 (4), 233-40
PubMed 9186533

Publications 1996

Brinch L (1996)
[Growth factors and cytokines in hematologic diseases. Use in aplastic anemia]
Tidsskr Nor Laegeforen, 116 (18), 2215
PubMed 8801671

Johnsen HE, Björkstrand B, Carlson K, Gruber A, Blystad A, Fast A, Boesen AM, Björkholm M, Sallerfors B, Ruutu T, Carneskog J, Malm A, Geisler C, Lehtinen M, Schrøder H, Brinch L, Remes K, Tidefelt U, Heilmann C, Hörnsten P, Thorling K, Daugaard G (1996)
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support
Leuk Lymphoma, 24 (1-2), 81-91
PubMed 9049964

Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Deliliers GL, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A (1996)
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)
Br J Haematol, 95 (4), 715-23
PubMed 8982051

Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Lambertenghi-Deliliers G, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A (1996)
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience
Bone Marrow Transplant, 17 Suppl 2, S40-6
PubMed 8722334

Stavem P, Brinch L, Brosstad F (1996)
[On co-authors and pathologists]
Tidsskr Nor Laegeforen, 116 (1), 110-1
PubMed 8553318

Steen R, Tjønnfjord GE, Gaudernack G, Brinch L, Egeland T (1996)
Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells
Br J Haematol, 94 (4), 597-605
PubMed 8826880

Publications 1995

Boberg KM, Brinch L, Vatn M (1995)
Crohn disease and the myelodysplastic syndrome
Ann Intern Med, 122 (5), 395
PubMed 7847659

Brinch L (1995)
[Patient information and conditioning for allogeneic stem cell transplantation]
Nord Med, 110 (12), 318-9, 322
PubMed 8524634

Lund MB, Kongerud J, Brinch L, Evensen SA, Boe J (1995)
Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide
Eur Respir J, 8 (8), 1269-74
PubMed 7489789

Sundan A, Ryan L, Brinch L, Espevik T, Waage A (1995)
The involvement of CD14 in stimulation of TNF production from peripheral mononuclear cells isolated from PNH patients
Scand J Immunol, 41 (6), 603-8
PubMed 7539547

Publications 1994

Brinch L, Evensen SA (1994)
[High-dose autologous stem cell administration in malignant diseases--an established method, unclear indications]
Tidsskr Nor Laegeforen, 114 (28), 3358
PubMed 7809897

Brinch L, Evensen SA, Egeland T, Solheim BG (1994)
[Infusion of hematopoietic stem cells from the blood. Simpler and better than bone marrow transplantation?]
Tidsskr Nor Laegeforen, 114 (19), 2242-3
PubMed 7992287

Evensen SA, Brinch L, Tjønnfjord G, Stavem P, Wisløff F (1994)
Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia
Br J Haematol, 88 (1), 88-93
PubMed 7803261

Stavem P, Brinch L, Hovig T (1994)
[The pitting function of the spleen visualized in a patient]
Tidsskr Nor Laegeforen, 114 (23), 2714-5
PubMed 7998011

Wisløff F, Brinch L, Bruserud O, Dahl IM, Lamvik J (1994)
[High-dose therapy with autologous stem cell support in malignant diseases]
Tidsskr Nor Laegeforen, 114 (26), 3115
PubMed 7974434

Wisløff F, Brinch L, Bruserud O, Dahl IM, Lamvik J (1994)
[Treatment with high-dose cytostatic agents]
Tidsskr Nor Laegeforen, 114 (26), 3115-6
PubMed 7974435

Publications 1993

Brinch L, Evensen SA, Albrechtsen D (1993)
Increasing age and survival after bone marrow transplant
JAMA, 270 (21), 2560
PubMed 8230641

Brinch L, Evensen SA, Blomhoff JP, Albrechtsen D (1993)
[Allogeneic bone marrow transplantation in adult patients with serious hematological diseases 1985-1992]
Tidsskr Nor Laegeforen, 113 (27), 3351-3
PubMed 8273060

Brinch L, Evensen SA, Blomhoff JP, Albrechtsen D (1993)
[Prioritizing in practice. Thinking about it, wishing it, then doing it!]
Tidsskr Nor Laegeforen, 113 (27), 3392-4
PubMed 8273070

Publications 1992

Brinch L, Evensen S, Albrechtsen D, Sinding-Larsen B (1992)
Fooled by blood cyclosporin levels
Bone Marrow Transplant, 9 (1), 77-8
PubMed 1543955

Brinch L, Evensen SA, Hammerstrøm J, Blichfeldt P (1992)
[New therapeutic possibilities for acquired clonal blood diseases and myelodysplasia]
Tidsskr Nor Laegeforen, 112 (18), 2343-5
PubMed 1412233

Brinch L, Stavem P (1992)
[Bone marrow puncture]
Tidsskr Nor Laegeforen, 112 (7), 915-6
PubMed 1557763

Brinch L, Stavem P, Evensen SA (1992)
[Treatment of acute hypergranular promyelocytic leukemia with all-trans-retinoic acid]
Tidsskr Nor Laegeforen, 112 (13), 1708-9
PubMed 1509429

Evensen SA, Brinch L, Albrechtsen D, Egeland T (1992)
[Radiation accidents]
Tidsskr Nor Laegeforen, 112 (23), 2991
PubMed 1412352

Evensen SA, Brinch L, Stavem P, Glomstein A, Solheim BG (1992)
[Avoiding the use of not virus-inactivated plasma]
Tidsskr Nor Laegeforen, 112 (18), 2389
PubMed 1412247

Evensen SA, Brinch L, Stavem P, Tjønnfjord G (1992)
Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy
J Intern Med, 232 (5), 433-7
PubMed 1453128

Evensen SA, Brinch L, Wisløff F, Talstad I, Waage A, Dahl IM (1992)
[Recommendation to uncritical use of granulocyte colony-stimulating factor (G-CSF)?]
Tidsskr Nor Laegeforen, 112 (24), 3122
PubMed 1281932

Stavem P, Evensen SA, Brinch L, Strømsheim JP (1992)
[How to differentiate myelogenous leukemia FAB-type 6 (erythroleukemia) from the myelodysplastic syndrome?]
Tidsskr Nor Laegeforen, 112 (19), 2557-8
PubMed 1412272

Publications 1991

Brinch L, Evensen SA, Albrechtsen D, Egeland T (1991)
[New therapeutic possibilities for leukemia in adults. Indications and progress measures for allogeneic bone marrow transplantation]
Tidsskr Nor Laegeforen, 111 (3), 316-9
PubMed 2000611

Brinch L, Evensen SA, Albrechtsen D, Egeland T, Solheim BG, Rollag H, Naalsund A, Jacobsen AB (1991)
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]
Tidsskr Nor Laegeforen, 111 (3), 311-5
PubMed 2000610

Publications 1990

Brinch L, Evensen SA, Albrechtsen D, Solheim BG (1990)
[Virus infections in patients with immune deficiency]
Tidsskr Nor Laegeforen, 110 (30), 3963-4
PubMed 2177923

BRINCH L, HANNISDAL E, ABRAHAMSEN AF, KVALOY S, LANGHOLM R (1990)
EXTRAMEDULLARY PLASMACYTOMAS AND SOLITARY PLASMA-CELL TUMORS OF BONE
Eur. J. Haematol., 44 (2), 131-134

Brinch L, Hannisdal E, Abrahamsen AF, Kvaløy S, Langholm R (1990)
[Diagnosis and treatment of solitary plasmacytoma]
Tidsskr Nor Laegeforen, 110 (12), 1515-6
PubMed 2339400

Brinch L, Hannisdal E, Abrahamsen AF, Kvaløy S, Langholm R (1990)
Extramedullary plasmacytomas and solitary plasma cell tumours of bone
Eur J Haematol, 44 (2), 132-5
PubMed 2318296

Brinch L, Rostad H, Mehl A, Blichfeldt P, Eng J (1990)
[Hairy cell leukemia and Mycobacterium malmoense infection]
Tidsskr Nor Laegeforen, 110 (7), 835-6
PubMed 2321208

Brinch L, Tjønnfjord G, Ly B (1990)
[Folic acid deficiency can cause severe anemia and pancytopenia]
Tidsskr Nor Laegeforen, 110 (14), 1830-1
PubMed 2363149

Publications 1989

Brinch L, Evensen SA, Stavem P, Smeland EB (1989)
[Experiences of immunologic phenotyping in acute leukemia]
Tidsskr Nor Laegeforen, 109 (4), 443-6
PubMed 2919374

Brinch L, Evensen SA, Stavem P, van der Hagen CB (1989)
[Cytogenetic analysis in acute leukemia]
Tidsskr Nor Laegeforen, 109 (4), 438-41
PubMed 2919373

Brinch L, Stavem P (1989)
[Treatment of hairy cell leukemia]
Tidsskr Nor Laegeforen, 109 (32), 3330-1
PubMed 2595704

Evensen SA, Brinch L, Wisløff F (1989)
[Recurrence or therapeutic resistance of acute myelogenous leukemia. Effect of mitoxantrone and cytosine arabinoside]
Tidsskr Nor Laegeforen, 109 (19-21), 2004-6
PubMed 2749689

Nygaard R, Moe PJ, Brincker H, Clausen N, Nyman R, Perkkiö M, Eilertsen ME, Johansen OJ, Väre M, Brinch L (1989)
Late relapses after treatment for acute lymphoblastic leukemia in childhood: a population-based study from the Nordic countries
Med Pediatr Oncol, 17 (1), 45-7
PubMed 2913474

Publications 1988

Brinch L, Evensen SA, Stavem P (1988)
Leukemia in the central nervous system
Acta Med Scand, 224 (2), 173-8
PubMed 3166601

Brinch L, Evensen SA, Stavem P, Solheim BG (1988)
[Use and abuse of platelet concentrates]
Tidsskr Nor Laegeforen, 108 (22), 1632-4
PubMed 3413751

Brinch L, Evensen SA, Stavem P, Svare A (1988)
[Neurological problems in leukemia]
Tidsskr Nor Laegeforen, 108 (22), 1587-9
PubMed 3413741

Publications 1987

Brinch L, Evensen SA, Stavem P (1987)
[Acute leukemia in the elderly]
Tidsskr Nor Laegeforen, 107 (4), 378-80
PubMed 3470976

Publications 1984

Brinch L, Emblem R, Hoel PS (1984)
[Microangiopathic hemolytic anemia in metastasized adenocarcinoma of the cardia]
Tidsskr Nor Laegeforen, 104 (10-11), 739-41
PubMed 6719413

Publications 1983

Brinch L, Blomhoff JP, Skrede S, Foerster A (1983)
[Parenteral amino acid therapy of liver damage after jejunoileal bypass]
Tidsskr Nor Laegeforen, 103 (23), 1644-5
PubMed 6636078

Brinch L, Aakesson I, Teisberg P, Enger E (1983)
The in vivo metabolism of C3 in human glomerulonephritis and after renal transplantation
Scand J Clin Lab Invest, 43 (7), 609-16
PubMed 6361976

Publications 1982

Brinch L, Teisberg P, Schrumpf E, Akesson I (1982)
The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis
Scand J Gastroenterol, 17 (4), 523-7
PubMed 7134879

Brinch L, Vinje O, Teisberg P, Mellbye OJ, Aakesson I (1982)
The in-vivo metabolism of C3 in ankylosing spondylitis
Ann Rheum Dis, 41 (1), 86-9
PubMed 7065734

Publications 1980

Brinch L, Teisberg P, Fausa O, Akesson I (1980)
The metabolism of C3 in adult coeliac disease
Scand J Gastroenterol, 15 (1), 33-8
PubMed 7367819

Brinch L, Aakesson I (1980)
Aseptic isolation of human complement component C3 for in vivo studies
Scand J Clin Lab Invest, 40 (5), 487-9
PubMed 7444351

Publications 1979

Brinch L, Teisberg P, Aakesson I (1979)
Metabolic studies of C3 in man
J Immunol Methods, 30 (1), 69-75
PubMed 512363

Publications 1978

Brinch L (1978)
[Attempted suicide with insulin]
Tidsskr Nor Laegeforen, 98 (9), 438-9
PubMed 653684

Teisberg P, Akesson I, Halvorsen S, Skjorten F, Brinch L (1978)
Hypercatabolism of the third component of complement (C3) in angioimmunoblastic lymphadenopathy
Scand J Haematol, 20 (5), 394-8
PubMed 663553